A Chronic Disease Management Solution

描述（由申请人提供）：Koronis Biomedical Technologies Corporation（KBT）提议开发慢性病管理解决方案。根据美国国立卫生研究院的数据，2005年慢性病将占美国医疗保健费用的75%。拟议的解决方案将服务于患有四种慢性疾病中的一种或多种的大量患者：糖尿病，充血性心力衰竭，慢性阻塞性肺病或哮喘。这些疾病占慢性病患者的80%。KBT提议与一家领先的医疗技术公司建立合作关系，该公司致力于在自我监测慢性疾病的患者和护理他们的医疗专业人员之间提供现代化的互动协作。拟议的项目将把开发的技术整合到一个商业化的疾病管理平台中，以创建一个新的慢性病管理解决方案， 商业成功的可能性。

DESCRIPTION (provided by applicant): Koronis Biomedical Technologies Corporation (KBT) proposes the development of a chronic disease management solution. According to the NIH, chronic diseases in 2005 will account for 75% of U.S. healthcare costs. The proposed solution will serve the large population of patients suffering from one or more of four chronic illnesses: diabetes, congestive heart failure, chronic obstructive pulmonary disease, or asthma. These diseases represent 80% of the patients with chronic disease. KBT proposes a teaming relationship with a pioneering healthcare technology company in the business of providing a modern, interactive collaboration between those patients who are self-monitoring a chronic condition and the health professionals that care for them. The proposed project will integrate the developed technology into a commercially available disease management platform to create a new chronic disease management solution that has a high probability of commercial success.